Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy.
Low Confidence ReviewPrimary source: [Open]
Linked compounds: tesamorelin
Outcomes summary
Review summarizing clinical evidence for tesamorelin in HIV-associated lipodystrophy, including effects on visceral adiposity and related metabolic measures.
Limitations
Review article; conclusions depend on included study quality and publication context.
Notes
Primary source: PMID 21668043.